BLEGD (Branded Legacy) Current Ratio: 1.49 (As of Dec. 2021)


What is Branded Legacy Current Ratio?

Branded Legacy BLEGD Current Ratio is 1.49 as of Dec. 2021.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Branded Legacy's current ratio for the quarter that ended in Dec. 2021 was 1.49.

Branded Legacy has a current ratio of 1.49. It generally indicates good short-term financial strength.

The historical rank and industry rank for Branded Legacy's Current Ratio or its related term are showing as below:

BLEGD's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2
* Ranked among companies with meaningful Current Ratio only.

Branded Legacy  (OTCPK:BLEGD) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Branded Legacy Current Ratio Related Terms


Branded Legacy Current Ratio Historical Data

* Premium members only.

The historical data trend for Branded Legacy's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Branded Legacy Current Ratio Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Current Ratio
Get a 7-Day Free Trial 0.11 0.88 6.37 2.90 1.49

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 3.25 2.78 2.98 1.49

BLEGD vs UPDC, RIBT, GDMK: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Branded Legacy's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Branded Legacy Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Branded Legacy's Current Ratio distribution charts can be found below:

* The bar in red indicates where Branded Legacy's Current Ratio falls into.



Branded Legacy Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Branded Legacy's Current Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Current Ratio (A: Dec. 2021 )=Total Current Assets (A: Dec. 2021 )/Total Current Liabilities (A: Dec. 2021 )
=0.106/0.071
=1.49

Branded Legacy's Current Ratio for the quarter that ended in Dec. 2021 is calculated as

Current Ratio (Q: Dec. 2021 )=Total Current Assets (Q: Dec. 2021 )/Total Current Liabilities (Q: Dec. 2021 )
=0.106/0.071
=1.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 1.49 mean?
Branded Legacy (BLEGD) has a Current Ratio of 1.49 as of Dec. 2021.
Is Branded Legacy's Current Ratio too high?
Branded Legacy's current Current Ratio is 1.49. The Drug Manufacturers industry median Current Ratio is 2.00. Branded Legacy's value of 1.49 is 25.5% below this industry median.
How does Branded Legacy's Current Ratio compare to UPDC and RIBT?
Branded Legacy's Current Ratio of 1.49 can be compared against companies in the Drug Manufacturers industry. The industry median Current Ratio is 2.00. Branded Legacy's value of 1.49 is 25.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Branded Legacy's current Current Ratio of 1.49 is 25.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Branded Legacy's current Current Ratio is 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEGD) has a current Current Ratio of 1.49. The current Current Ratio is 1.49 and 25.5% below the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Branded Legacy (BLEGD), the current Current Ratio is 1.49 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Branded Legacy Business Description

Address 751 North Drive, Suite 9, Melbourne, FL, USA, 32934
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.